🇺🇸 FDA
Patent

US 11806408

Methods and compositions for treating cone-rod retinal dystrophy

granted A61KA61K35/761A61K48/005

Quick answer

US patent 11806408 (Methods and compositions for treating cone-rod retinal dystrophy) held by Editas Medicine, Inc. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Editas Medicine, Inc.
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K35/761, A61K48/005, A61K48/0075